Evidence map›Paper›PMID 41918870›Full record

ArticleEndocrine oncology (Bristol, England)2026

Mesenteric paraganglioma mimicking nodal metastasis of an occult small intestinal neuroendocrine tumor.

Anna Battistella, Marco Schiavo Lena, Valentina Andreasi, Stefano Partelli, Massimo Falconi

Abstract readCase Reports
In one paragraph

Article in Endocrine oncology (Bristol, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna BattistellaVita-Salute San Raffaele University, Milan, Italy.
Marco Schiavo LenaPathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Valentina AndreasiVita-Salute San Raffaele University, Milan, Italy.
Stefano PartelliVita-Salute San Raffaele University, Milan, Italy.ORCID https://orcid.org/0000-0001-8938-6170
Massimo FalconiVita-Salute San Raffaele University, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paragangliomas (PGLs) are rare neuroendocrine neoplasms of neural-crest origin, with primary mesenteric localization representing an exceptionally uncommon entity that is rarely considered in the preoperative differential diagnosis of mesenteric masses. We report the case of a 51-year-old woman who was referred to our institute following the incidental detection of a 12 × 9 mm hypervascular nodule within the pelvic small bowel mesentery on contrast-enhanced computed tomography (CT). Subsequent Learning points: Primary mesenteric paragangliomas should be considered in the differential diagnosis of solitary, hypervascularized mesenteric masses.A solitary SSTR-avid mesenteric nodule in an asymptomatic, biochemically silent patient does not necessarily imply nodal metastasis from an occult small intestinal neuroendocrine tumor.Considering alternative diagnoses may avoid unnecessary endoscopic, radiological, and surgical investigations for an intestinal primary lesion.Definitive diagnosis and risk stratification rely on histopathology and immunohistochemistry, including epithelial markers, GATA3, and SDHB.Awareness of mesenteric paraganglioma as a diagnostic mimic can prevent overtreatment and guide appropriate surgical management.

Indexed as

neuroendocrine tumorsnodal metastasesparagangliomaSI-NET

Identifiers

PMID41918870
PMCPMC13034518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.